Send to

Choose Destination
Scand J Gastroenterol Suppl. 1997;222:100-1. doi: 10.1080/00365521.1997.11720730.

Lactulose and renal failure.

Author information

Dept. of Internal Medicine, University Hospital of Berne, Switzerland.


The introduction of lactulose as a new therapeutic agent for treatment of hepatic encephalopathy was a major breakthrough in this field. It was hypothesized that lactulose might prevent postoperative renal impairment after biliary surgery in patients with obstructive jaundice. The presumable mechanism purported was the diminished endotoxinemia by lactulose. Unfortunately, such a reno-protective effect has not been shown conclusively until now in clinical studies. In chronic renal failure lactulose is known to promote fecal excretion of water, sodium, potassium, amonium, urea, creatinine and protons. Thus, lactulose could be useful for the treatment of chronic renal failure. However, compliance to the therapy represents a major problem.

[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center